A new study reveals how targeted electromagnetic waves can disrupt the SARS-CoV-2 spike protein, potentially opening doors to innovative disinfection and infection control strategies. Study: ...
Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...
The JN.1 subvariant of SARS-CoV-2 emerged in late 2023 and rapidly became dominant globally. In the past 6 months, JN.1 has continued to evolve, giving rise to multiple sublineages with unique spike ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...
New study reveals how lingering spike protein in the brain's borders could explain long-term COVID-19 neurological symptoms and highlight vaccines' protective role. Study: Persistence of spike protein ...
Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants. A new approach now exploits a llama-derived nanobody—VHH21—that ...
Decisions made by researchers during the microliter, benchtop development of biotherapeutics made from monoclonal antibodies (mAb) and recombinant proteins often don’t scale to larger stirred tank ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ — Javelin Sciences, a pioneering certified biotechnology laboratory specializing in advanced ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results